Carmen Balaña has a degree in Medicine and Surgery from the UB and a Ph.D. in Medicine from the UAB. She is an MIR specialist in Medical Oncology (Hospital Vall d'Hebrón), and an Associate Professor at the UAB. She is the director of three doctoral theses and is in the process of directing four more. She is the author or co-author of 174 articles, the principal investigator of 4 competitive projects (2 ISCIII), and a collaborator in four more. A member of the Clinical Research Ethics Committee of the Germans Trias i Pujol Hospital, she has been vice-president since June 2015. Principal investigator of more than 60 clinical studies, most of them focused on tumors of the central nervous system, she is also a member of the Pharmacotherapeutic Commission of the Institut Catala d'Oncologia (2009--2017). She is a member of the Spanish Neuro-oncology Research Group, of which she was president, and is currently a member of the Board of Directors. She is a member of the Scientific Committee of the European Association of Neuro-Oncology (EANO) and of the Congresses of the European Society of Medical Oncology (2014--2018). She is a member of the Editorial Board of Neuro-Oncology (Q1) and of Clinical Translational Oncology (until 2013). She is an article reviewer for 'Lancet Oncology', 'Cancer Medicine', 'Cancer Medicine', and 'BMC', among others